Position in TLRY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$716,874
-$286,574 QoQ
Shares Held
110,800
-0.3% QoQ
Ownership
0.095%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TLRY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026NORTHERN TRUST CORP holds $2,144,504,710 across 53 Drug Manufacturers - Specialty & Generic names. TLRY ranks #43 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,546,057 | $655,599,395 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
436,566 | $258,874,903 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
7,635,688 | $229,986,920 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
1,242,830 | $163,730,421 | |
| 5 | VTRS |
Viatris Inc
|
10,451,364 | $141,197,922 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
4,189,189 | $100,247,290 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
804,923 | $61,053,407 | |
| 8 | ALKS |
Alkermes plc.
|
1,697,082 | $60,008,815 |
All Filings in TLRY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $716,874 | 110,800 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,003,448 | 111,124 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||